Skip to main content

Table 2 Pathological data

From: Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

 

SURG (n = 32)

TACE (N = 16)

SIRT (N = 12)

P

Tumor differentiation

0.51

 Well

10 (31.2%)

5 (31.2%)

3 (25%)

 

 Moderate

18 (56.2%)

10 (62.5%)

6 (50%)

 

 Poorly

4 (12.5%)

1 (6.25%)

3 (25%)

 

Tumor necrosis

< 0.001

 Absence

26 (81.2%)

1 (6.25%)

3 (25%)

 

 Minor (1–25%)

4 (12.5%)

2 (12.5%)

1 (8.3%)

 

 Moderate (25–50%)

2 (6.25%)

3 (18.75%)

2 (16.6%)

 

 Major (> 50%)

0

5 (31.2%)

4 (33.3%)

 

 Complete (100%)

0

5 (31.2%)

2 (16.6%)

 
  1. SURG surgery, TACE transarterial chemoembolization, SIRT selective internal radiation therapy